X
Sanofi hands back neurology gene therapy rights to Voyager
https://pharmaphorum.com/news/sanofi-hands-back-neurology-gene-therapy-rights-to-voyager/
Huntington’s disease
Huntington’s Disease wearable gets backing from NIH
BioSensics’ HDWear provides real-time motor function scores in Huntington’s patients.
FDA approves Teva’s Huntington’s Disease drug
First treatment approved for Huntington’s Disease in almost a decade.
Teva files orphan blockbuster hope in tardive dyskinesia
SD-809 will be vital for Teva if approved.
Teva takes another shot with Huntington’s drug in US
FDA rejected drug earlier this year.
Teva collaborates with Intel to develop Huntington’s smartwatch
Teva enters the machine learning market.